Acumen Pharmaceuticals, Inc.
ABOS
$1.36
-$0.05-3.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -44.96% | -40.93% | -29.55% | -7.00% | 79.78% |
| Total Receivables | 430.19% | 274.07% | 57.00% | 92.17% | -53.30% |
| Inventory | -- | -- | 62.24% | 113.43% | -95.48% |
| Prepaid Expenses | 77.89% | 17.03% | 6.32% | -16.86% | 171.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -29.68% | 77.69% | 185.46% | 239.13% | 256.49% |
| Total Current Assets | -44.40% | -39.43% | -27.70% | -5.02% | 78.49% |
|
|
|||||
| Total Current Assets | -44.40% | -39.43% | -27.70% | -5.02% | 78.49% |
| Net Property, Plant & Equipment | -22.09% | -20.64% | -32.60% | 208.00% | 160.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -69.89% | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -24.16% | -17.47% | -16.52% | 7.41% | 21.74% |
| Total Assets | -40.50% | -32.06% | -22.94% | -6.77% | 62.86% |
|
|
|||||
| Total Accounts Payable | -50.06% | -65.70% | 309.57% | 71.95% | 107.85% |
| Total Accrued Expenses | 106.35% | 269.51% | 105.40% | 270.56% | 68.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.60% | 14.05% | -84.64% | 6,350.00% | 331.03% |
| Total Finance Division Other Current Liabilities | 8.05% | -13.10% | 8.49% | 148.15% | 645.00% |
| Total Other Current Liabilities | 8.05% | -13.10% | 8.49% | 148.15% | 645.00% |
| Total Current Liabilities | 61.78% | 127.99% | 112.84% | 226.57% | 80.13% |
|
|
|||||
| Total Current Liabilities | 61.78% | 127.99% | 112.84% | 226.57% | 80.13% |
| Long-Term Debt | 1.71% | -2.25% | -1.60% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -64.84% | -54.76% | -47.18% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.91% | 25.75% | 32.50% | 716.22% | 427.09% |
|
|
|||||
| Common Stock & APIC | 1.91% | 1.92% | 3.58% | 3.61% | 38.43% |
| Retained Earnings | -52.93% | -48.91% | -45.93% | -39.59% | -33.55% |
| Treasury Stock & Other | 114.02% | 110.42% | -115.38% | 201.77% | 74.61% |
| Total Common Equity | -52.01% | -40.65% | -31.90% | -22.50% | 44.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -52.01% | -40.65% | -31.90% | -22.50% | 44.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -52.01% | -40.65% | -31.90% | -22.50% | 44.46% |
|
|
|||||